ABSTRACT Receptors for calcitonin, as assayed by the specific binding of 'SI-labeled salmon calcitonin and stimulation of cyclic AMP formation, were found in 886 cels derived from a human lymphoid line. The affinity of calcitonin from different species and of various analogues of human calcitonin for the binding sites and their ability to stimulate cyclic AMP formation were closely related to their hypocalcemic activity and presumably reflected biological properties of the hormones. Cell Culture, Isolation, and Incubation. The 8866 cells were derived from a patient with chronic myelogeneous leukemia (6) and were generously provided by S. J. Marx (NIAMDD). They were cultured in RPMI 1640 medium with 2 mM L-glutamine, supplemented with 10% fetal calf serum (vol/vol; Gibco, Glasgow, Scotland) and 0.5 ,ug of neomycin sulfate per ml, under a humid atmosphere of 95% air/5% CO2 at 370. Cells were fed two to three times weekly by 1:3 dilution in fresh growth medium. The cells were harvested at the late phase of exponential growth by sedimentation for 10 min at 300 X g at 40, washed three times in the incubation medium, and resuspended to a density of 107 cells per ml.
Calcitonin is a polypeptide hormone that causes hypocalcemia by means of inhibition of the release of calcium from bone and stimulation of urinary calcium excretion (1, 2) . The initial step of the action of calcitonin is binding to receptors on plasma membranes of renal and bone cells (3) . Subsequently and prior to the characteristic biological response, the formation of cyclic AMP (cAMP) is stimulated (3, 4) . Additional receptors for calcitonin have been found on bronchial epidermoid carcinoma cells (5) and on cultured human lymphocytes (6) . Marx et al. (6) have demonstrated calcitonin-specific binding sites, and we have found a stimulation of cAMP formation in 8866 cells de- rived from a patient with chronic myelogenous leukemia (7) .
In the present report we have confirmed the binding characteristics of '25I-labeled salmon calcitonin (125I-calcitonin) to 8866 cells and present evidence that binding correlated with the stimulation of cAMP formation and the hypocalcemic activity of various calcitonins. In view of the close relationship between changes in calcium and cAMP concentrations (8) , we have studied the influence of extracellular calcium and calcium ionophores on calcitonin binding and on basal and calcitoninstimulated cAMP formation.
MATERIALS AND METHODS
Synthetic human calcitonin-(1-32) and analogues thereof, porcine calcitonin-(1-32), human parathyroid hormone -(1-34) corresponding to the structure obtained by Brewer et al. (9) , adrenocorticotropin (ACTH)- , somatostatin, and purified porcine insulin were donated by W. Rittel (10) were iodinated with chloramine-T as described (11) on Bio-Gel P-6. The radioactivity eluted from the cells with 0.1 M acetic acid consisted predominantly of fragments of salmon calcitonin both in the absence and presence of ACTH; binding of fragments of radioactive salmon calcitonin to 8866 cells varied between 30 and 70%, but the binding could not be inhibited by 50 nM unlabeled salmon calcitonin (not shown).
cAMP Formation. As shown in Fig. 2 , cAMP levels were already maximal in the cells after 5 min of incubation in the presence of salmon calcitonin. The time of appearance of the peak of cAMP concentrations in the cells was somewhat unpredictable, and total cAMP in the cells and incubation medium was therefore determined in most of the experiments; maximal total cAMP levels were observed between 5 and 15 min. Preincubation of the cells for various time intervals of up to 120 min in the absence of calcitonin did not affect the subsequent increase of cAMP levels by calcitonin. However, a second addition of calcitonin 30 min after the first addition did not significantly raise cAMP levels (7). The calcitonin-stimulated cAMP formation was linearly related to a cell density of up to 1.6 X 107 cells/ml. Fragments of salmon calcitonin generated during incubation for 360 min did not stimulate cAMP formation (not shown). Specifity. The displacement of specifically bound salmon 125I-calcitonin by unlabeled salmon, porcine, and human calcitonins and several analogues of the human hormone is shown in Fig. 3 (Fig. 4) . In this case the order of ability to stimulate cAMP formation was salmon calcitonin, human [Tyr22]calcinonin, human [Leu'2"16"9Tyr22]-calcitonin, human [Arg24Jcalcitonin, porcine calcitonin, human calcitonin, and human calcitonin-OH. In Fig. 5 the relative binding inhibition of the various calcitonins and their relative ability to stimulate cAMP accumulation is compared to their hypocalcemic activity (10, (15) (16) (17) (18) . The concentrations of calcitonin causing half-maximal inhibition of binding and halfmaximal stimulation of cAMP formation were comparable and corresponded reasonably well to their hypocalcemic activity.
Besides calcitonin, prostaglandin E1, isoprotenerol, norepinephrine, and epinephrine stimulated cAMP formation, whereas ACTH-(1-24), growth hormone, insulin, parathyroid hormone, somatostatin, 1,25-dihydroxycholecalciferol, and 3,3',5-triiodothyronine were inactive ( Table 1 ). The stimulation with isoproterenol and the suppression with propranolol suggest the existence of fl-adrenergic receptor sites. These sites are probably not linked to the stimulation of cAMP formation by salmon calcitonin, which is not influenced by the addition of propranolol.
Extracellular Calcium and Calcium Ionophores in Binding of Salmon l25I-Calcitonin and cAMP Formation. Addition of calcium, EGTA, and the calcium ionophores A23187 and Br-X-537A to the incubation medium did not affect the specific binding of salmon 125I-calcitonin to 8866 cells. Nonspecific binding was raised from 2% to 10% in the presence of the A23187, but remained unchanged with Br-X-537A, calcium, and EGTA (not shown).
Calcium and EGTA did not influence cAMP levels, whereas Br-X-537A inhibited basal and calcitonin-stimulated cAMP formation (Fig. 6) a:---I --EGTA + Br-X-537A a higher binding affinity than human calcitonin for the 8866 cells, but it also had a greater ability to stimulate cAMP formation. This is further evidence for the evolution of human calcitonin to an intrinsically less potent form of the hormone. Substitutions of amino acids in the structure of human calcitonin towards the structure of the salmon hormone results in a potentiation of the affinity and potency of the human hormone in the 8866 cells, which reasonably well agree with their hypocalcemic activity (10, (15) (16) (17) (18) . We cannot exclude the existence of separate high-affinity binding sites for labeled human or porcine calcitonins that are not detected with salmon 125I-calcitonin. The results obtained in 8866 cells, however, reflect biological properties of calcitonin.
The functional significance of calcitonin, 0-adrenergic, and prostaglandin E1 receptors coupled to the stimulation of cAMP formation remains to be elucidated. In mixed cell preparations from rat thymus, salmon calcitonin inhibited apparently cAMP-mediated stimulation by epinephrine of thymocyte proliferation (19) . On the other hand, the calcitonin did not affect [3H]thymidine incorporation into 8866 cells (not shown).
The behavior of 8866 cells may not be comparable to rat thymocytes. Characteristic biological responses of calcitonin in leukemic cells have not been detected. The role of cAMP as a second messenger is widely accepted, whereas the mode of action of calcium as a coupling factor is complex (8) . In the present study, calcitonin stimulated and Br-X-537A suppressed cAMP formation in the absence and presence of extracellular calcium; A23187, on the other hand, only suppressed cAMP levels in the presence of calcium added to the incubation medium. Calcitonin-specific binding was unrelated to the calcium concentration and was not affected by the presence of calcium ionophores. Furthermore, as in turkey erythrocytes (20) and human leukocytes (21), cAMP levels were not influenced by changes of the calcium concentration in the medium. A23187 stimulated the calcium-dependent secretion of histamine from mast cells (22) provided calcium was present in the incubation medium, whereas Br-X-537A enhanced the release of oxytocin from the neurohypophysis in the absence of added external calcium (23) . There is evidence that A23187 not only transports calcium across plasma membranes, but also stimulates calcium efflux from internal, most likely mitochondrial, stores (24) (25) (26) , whereas Br-X-537A appears to release calcium from intracellular binding sites only (23) . A23187, on the other hand, had no direct effect on the activity of the adenylyate cyclase in turkey erythrocytes (21) . If Br-X-537A and A23187 increase, as is generally believed, the free calcium concentration in the cytosol (27, 28) , they probably decrease adenylyate cyclase activity by raising cytosolic calcium levels.
The data may also imply that a fall of the calcium concentration in the cytosol is associated with calcitonin-stimulated increase of cAMP in cultured human lymphocytes. Inasmuch as the extracellular calcium concentration did not influence the cAMP responses to calcitonin, the hormone possibly stimulated the translocation of calcium from the cytosol to intracellular binding sites. This is in line with the findings of Borle (29) , who presented evidence that calcitonin stimulated the rate of calcium uptake into kidney mitochondria. On the other hand, in contrast to the lack of an effect of A23187 on adenylyate cyclase activity (21) , calcitonin directly stimulates the enzymatic activity in kidney and bone cells (3, 4) . Nevertheless, EGTA stimulated and calcium suppressed calcitonin-sensitive adenylyate cyclase activity (30, 31) . Finally, a stimulation of a calcium-sensitive cAMP phosphodiesterase cannot be ruled out, but appears unlikely, since EGTA had no effect on phosphodiesterase activators of normal and leukemic lymphocytes (32) .
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